Janssen Pharmaceuticals was purchased by Johnson & Johnson in 1961 and became part of Johnson & Johnson Pharmaceutical Research and Development which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anesthesia and analgesia, allergies and cancer.